AER 1603214 is a spontaneous case, received on 02/Jul/2015, from a physician via Lakemedelsverket (MPA - 
Medical Products Agency) (country: Sweden, reference number: 2015001840) and concerns a 72 year old female 
patient who died due to progressive multifocal leucoencephalopathy whilst being treated with rituximab.
No medical history, concurrent illnesses, concomitant medication or past drugs were reported.
On an unspecified date, the patient started therapy with intravenous rituximab (form, dose and frequency not 
reported) for unknown indication. On an unspecified date, he died due to progressive multifocal 
leukoencephalopathy. It was not reported, if an autopsy was performed or not.
At the time of death, the therapy status with rituximab was not reported.
The physician did not report the causality between progressive multifocal leucoencephalopathy and rituximab.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 108 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
No further information was provided.